Search for: "Pfizer Inc." Results 601 - 620 of 1,516
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Mar 2013, 4:26 pm
Nursing home to pay $2.7M for False Claims Act violations, Legal Newsline, March 25, 2013 Tennessee-Based Therapy Providers to Pay $2.7 Million to Resolve False Claims Act Allegations, US DOJ, March 8, 2013 More Blog Posts: Whistleblower Lawsuit Accuses Dialysis Company DaVita Inc. of Overbilling Medicare and Medicaid by Hundreds of Millions of Dollars, Boston Injury Lawyer Blog, December 22, 2013 $25M Whistleblower Settlement Reached in Hospice Fraud Case Against Odyssey Healthcare… [read post]
11 Sep 2017, 5:35 pm by Lawrence B. Ebert
").CaseBRISTOL~MYERS SQUIBB COMPANY and PFIZER INC v, Mylan ["MPI"], 2017 U.S. [read post]
23 Jun 2011, 11:14 pm by Carey, Danis & Lowe, L.L.C.
A patent infringement lawsuit that Wyeth, the makers of Effexor, filed against Intellipharmaceutics International Inc. has been settled. [read post]
24 Jan 2019, 8:35 am by McLaughlin & Nardi, LLC
Pfizer, Inc., the Appellate Division invalidated an electronic arbitration agreement used by Pfizer for all its employees. [read post]
11 Jun 2007, 3:43 am
(order) (06/08/2007, non-precedential): Mylan moved for summary reversal of the judgment and amended judgment of the district court, of which Pfizer opposes; in a separate case (Pfizer, Inc. v. [read post]
6 Jun 2016, 12:21 pm by Tom Kosakowski
Shore, Vice President and Chief Ombudsman, CO-OP®, Office of the Ombudsman, Pfizer Inc.; Joan Waters, University Ombuds Officer, Columbia University; James Hurst, Agency Staff Attorney, NYC Department of Consumer Affairs; Nancy Deering, Newark Public Schools and IOAProgram Description: Explore the impact of the ombuds role in advancing conflict resolution and ADR. [read post]
18 Apr 2021, 5:21 pm by Juvan Bonni
Recent Headlines in the IP World: Kim Yun-Mi: BMS, Pfizer Win Final Suit for Eliquis Patent (Source: Korea Biomedical Review) David Hyman: Rakovina Therapeutics Inc. [read post]
15 May 2021, 6:00 pm by Juvan Bonni
 Bashar Malkawi: Royalty Rate Determination in Patent Infringement Cases: The U.S. and China Compared (Source: SSRN) New Job Postings on Patently-O: Boston Scientific Clark+Elbing LLP Warner Norcross + Judd LLP – Patent Associate Attorney Warner Norcross + Judd LLP – Patent Agent Weaver Austin Villeneuve & Sampson LLP Murphy, Bilak & Homiller PLLC (MBH) McNeill Baur Faegre Drinker ALG Intellectual Property, LLC PTC Therapeutics Inc Miller & Martin Workman… [read post]
4 Feb 2021, 1:17 pm by Tom Kosakowski
Here are the nominees along links to any information published on the Ombuds Blog:Roy Baroff, CO-OP (incumbent) — Faculty & Staff Ombuds, North Carolina State University;Suzanne Diviney, CO-OP (incumbent) — Vice President, Office of the Ombuds Lead, Pfizer Inc. [read post]
6 Jan 2014, 6:45 am by David Jensen
(TEVA) of Petach Tikva, Israel, and Pfizer(PFE) Inc. of New York are working with stem-cell researchers on new therapies. [read post]
2 Jan 2020, 9:25 am by Beth Mole
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week. [read post]
21 Jun 2010, 7:12 am
Recently, the first trial date was set in a group of over 8,000 personal injury and product liability lawsuits pending against Pfizer, Inc., claiming its menopause drug Prempro is a defective and dangerous product because it has been linked to breast cancer. [read post]